Author Instructions: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
*For a Word document template for authoring a disease-specific page before transferring content online please click here ???. | *For a Word document template for authoring a disease-specific page before transferring content online please click here ???. | ||
*For a Word document template for authoring an overview page before transferring content online, please click here ???. | *For a Word document template for authoring an overview page before transferring content online, please click here ???. | ||
| Line 46: | Line 45: | ||
#Naeini Y, Quintero-Rivera F. “Myeloid Sarcoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated 2020 Jan 2 [accessed 2020 July 5], [[Myeloid Sarcoma|www.ccga.io/index.php/Myeloid_Sarcoma]]. | #Naeini Y, Quintero-Rivera F. “Myeloid Sarcoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated 2020 Jan 2 [accessed 2020 July 5], [[Myeloid Sarcoma|www.ccga.io/index.php/Myeloid_Sarcoma]]. | ||